Table 2 Procedural characteristics of patients enrolled
Total | Low SHR group (SHR < 1.191) | High SHR group (SHR ≥ 1.191) | P value | |
|---|---|---|---|---|
Angiography | ||||
Number of diseased vessels | 0.615 | |||
1-vessel disease | 61 (48.0%) | 28 (44.4%) | 33 (51.6%) | |
2-vessel disease | 38 (29.9%) | 19 (30.2%) | 19 (29.7%) | |
3-vessel disease | 28 (22.0%) | 16 (25.4%) | 12 (18.8%) | |
TIMI flow (Pre-PCI) | 0.687 | |||
Grade 0 | 99 (78.0%) | 51 (81.0%) | 48 (75.0%) | |
Grade 1 | 24 (18.9%) | 10 (15.9%) | 14 (21.9%) | |
Grade 2 | 4 (3.1%) | 2 (3.2%) | 2 (3.2%) | |
Grade 3 | 0 | – | – | |
Gensini score | 58.00 (40.00, 80.00) | 48.00 (38.00,80.00) | 80.00 (49.00,84.00) | 0.001 |
Syntax score | 17.75 ± 6.03 | 16.35 ± 6.23 | 19.13 ± 5.53 | 0.009 |
Intervention therapy | ||||
Total ischemic time (min) | 422.53 ± 143.43 | 440.79 ± 122.29 | 404.55 ± 160.52 | 0.155 |
Stent implantation | 127 (100.0%) | 63 (100.0%) | 64 (100.0%) | 1.000 |
Number of stents | 1.29 ± 0.54 | 1.30 ± 0.56 | 1.28 ± 0.52 | 0.832 |
Length of stents (mm) | 34.28 ± 17.29 | 33.95 ± 18.38 | 34.59 ± 16.29 | 0.835 |
Diameter of stent (mm) | 3.05 ± 0.41 | 3.04 ± 0.44 | 3.06 ± 0.37 | 0.796 |
Thrombus aspiration (%) | 50 (39.4%) | 18 (28.6%) | 32 (50.0%) | 0.018 |
GP IIb/IIIa inhibitor (%) | 70 (55.1%) | 33 (52.4%) | 37 (57.8%) | 0.594 |
TIMI flow ≥ 2 (Post-PCI) | 120 (94.5%) | 61 (96.8%) | 59 (92.2%) | 0.440 |